[1] Chow CK, Teo KK, Rangarajan S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA, 2013; 310, 959−68. doi:  10.1001/jama.2013.184182
[2] NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet, 2017; 389, 37−55. doi:  10.1016/S0140-6736(16)31919-5
[3] Wang ZW, Chen Z, Zhang LF, et al. Status of hypertension in China: results from the China hypertension survey, 2012-2015. Circulation, 2018; 137, 2344−56. doi:  10.1161/CIRCULATIONAHA.117.032380
[4] Lu JP, Lu Y, Wang XC, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet, 2017; 390, 2549−58. doi:  10.1016/S0140-6736(17)32478-9
[5] Li YC, Yang L, Wang LM, et al. Burden of hypertension in China: a nationally representative survey of 174, 621 adults. Int J Cardiol, 2017; 227, 516−23. doi:  10.1016/j.ijcard.2016.10.110
[6] Wu YF, Huxley R, Li LM, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation, 2008; 118, 2679−86. doi:  10.1161/CIRCULATIONAHA.108.788166
[7] Guo J, Zhu YC, Chen YP, et al. The dynamics of hypertension prevalence, awareness, treatment, control and associated factors in Chinese adults: results from CHNS 1991-2011. J Hypertens, 2015; 33, 1688−96. doi:  10.1097/HJH.0000000000000594
[8] Ma WJ, Tang JL, Zhang YH, et al. Hypertension prevalence, awareness, treatment, control, and associated factors in adults in southern China. Am J Hypertens, 2012; 25, 590−6. doi:  10.1038/ajh.2012.11
[9] Lao XQ, Xu YJ, Wong MCS, et al. Hypertension prevalence, awareness, treatment, control and associated factors in a developing southern Chinese population: analysis of serial cross-sectional health survey data 2002-2010. Am J Hypertens, 2013; 26, 1335−45. doi:  10.1093/ajh/hpt111
[10] Li W, Gu HQ, Teo KK, et al. Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47 000 people from China. J Hypertens, 2016; 34, 39−46. doi:  10.1097/HJH.0000000000000745
[11] Olsen MH, Angell SY, Asma S, et al. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. Lancet, 2016; 388, 2665−712. doi:  10.1016/S0140-6736(16)31134-5
[12] Yang TC, Noah AJ, Shoff C. Exploring geographic variation in US mortality rates using a spatial Durbin approach. Popul Space Place, 2015; 21, 18−37. doi:  10.1002/psp.1809
[13] Safford MM, Reshetnyak E, Sterling MR, et al. Number of social determinants of health and fatal and nonfatal incident coronary heart disease in the REGARDS study. Circulation, 2021; 143, 244−53. doi:  10.1161/CIRCULATIONAHA.120.048026
[14] Leng B, Jin YN, Li G, et al. Socioeconomic status and hypertension: a meta-analysis. J Hypertens, 2015; 33, 221−9. doi:  10.1097/HJH.0000000000000428
[15] Banks J, Marmot M, Oldfield Z, et al. Disease and disadvantage in the United States and in England. JAMA, 2006; 295, 2037−45. doi:  10.1001/jama.295.17.2037
[16] Satoh A, Arima H, Ohkubo T, et al. Associations of socioeconomic status with prevalence, awareness, treatment, and control of hypertension in a general Japanese population: NIPPON DATA2010. J Hypertens, 2017; 35, 401−8. doi:  10.1097/HJH.0000000000001169
[17] Vathesatogkit P, Woodward M, Tanomsup S, et al. Long-term effects of socioeconomic status on incident hypertension and progression of blood pressure. J Hypertens, 2012; 30, 1347−53. doi:  10.1097/HJH.0b013e32835465ca
[18] Yu ZJ, Nissinen A, Vartiainen E, et al. Associations between socioeconomic status and cardiovascular risk factors in an urban population in China. Bull World Health Organ, 2000; 78, 1296−305.
[19] Li X, Krumholz HM, Yip W, et al. Quality of primary health care in China: challenges and recommendations. Lancet, 2020; 395, 1802−12. doi:  10.1016/S0140-6736(20)30122-7
[20] Zhao ZP, Zhang M, Wu J, et al. E-cigarette use among adults in China: findings from repeated cross-sectional surveys in 2015-16 and 2018-19. Lancet Public Health, 2020; 5, e639−49. doi:  10.1016/S2468-2667(20)30145-6
[21] Chinese Center for Disease Control and Prevention, National Center for Chronic and Non-Communicable Disease Control and Prevention. Report on chronic disease risk factors surveillance in China. Military Medical Science Press. 2016. (In Chinese)
[22] Li YC, Wang LM, Feng XQ, et al. Geographical variations in hypertension prevalence, awareness, treatment and control in China: findings from a nationwide and provincially representative survey. J Hypertens, 2018; 36, 178−87. doi:  10.1097/HJH.0000000000001531
[23] Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens, 2007; 25, 1105−87. doi:  10.1097/HJH.0b013e3281fc975a
[24] World Health Organization. Body Mass Index (BMI). https://www.who.int/data/gho/data/themes/theme-details/GHO/body-mass-index-(bmi)?introPage=intro_3.html. [2021-03-21].
[25] Zhang M, Deng Q, Wang LH, et al. Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: a nationally representative survey of 163, 641 adults. Int J Cardiol, 2018; 260, 196−203. doi:  10.1016/j.ijcard.2017.12.069
[26] Dobis EA, Stephens HM, Skidmore M, et al. Explaining the spatial variation in American life expectancy. Soc Sci Med, 2020; 246, 112759. doi:  10.1016/j.socscimed.2019.112759
[27] Jiang YY, Mao F, Li YC, et al. Construction of China cardiovascular health index. BMC Public Health, 2018; 18, 937. doi:  10.1186/s12889-018-5647-7
[28] National Bureau of Statistics of China. Annual by province. https://data.stats.gov.cn/english/easyquery.htm?cn=E0103. [2021-03-21].
[29] Nilima, Puranik A, Shreenidhi SM, et al. Spatial evaluation of prevalence, pattern and predictors of cervical cancer screening in India. Public Health, 2020; 178, 124−36. doi:  10.1016/j.puhe.2019.09.008
[30] Rytkönen MJP. Not all maps are equal: GIS and spatial analysis in epidemiology. Int J Circumpolar Health, 2004; 63, 9−24.
[31] Cliff AD, Ord JK. Spatial processes: models & applications. Pion. 1981.
[32] Melix BL, Uejio CK, Kintziger KW, et al. Florida neighborhood analysis of social determinants and their relationship to life expectancy. BMC Public Health, 2020; 20, 632. doi:  10.1186/s12889-020-08754-x
[33] Anselin L. Exploring spatial data with GeoDaTM: a workbook. Santa Barbara: Center for Spatially Integrated Social Science, 2005; 198−9.
[34] Anselin L, Bera AK, Florax R, et al. Simple diagnostic tests for spatial dependence. Reg Sci Urban Econ, 1996; 26, 77−104. doi:  10.1016/0166-0462(95)02111-6
[35] LeSage JP, Pace RK. Introduction to spatial econometrics. CRC Press. 2009.
[36] Anselin L, Florax RJGM, Rey SJ. Advances in spatial econometrics: methodology, tools and applications. Springer. 2004.
[37] Elhorst JP. Spatial econometrics: from cross-sectional data to spatial panels. Springer. 2014.
[38] Anselin L. Spatial econometrics: methods and models. Kluwer Academic Publishers. 1988.
[39] Arora V, Vamvakidis A. Economic spillovers: exploring the impact trading partners have on each other's growth. Finance Dev, 2005; 42, 48−50.
[40] Anselin L. Spatial externalities. Int Regional Sci Rev, 2003; 26, 147−52. doi:  10.1177/0160017602250971
[41] Audretsch DB. Innovation and spatial externalities. Int Regional Sci Rev, 2003; 26, 167−74. doi:  10.1177/0160017602250973
[42] Festinger L. A theory of social comparison processes. Human Relat, 1954; 7, 117−40. doi:  10.1177/001872675400700202
[43] National Health Commission of the People's Republic of China, Ministry of Finance of the People's Republic of China, National Administration of Traditional Chinese Medicine. Notice on the work of national basic public health service project in 2020. http://www.gov.cn/zhengce/zhengceku/2020-06/16/content_5519776.htm. [2021-03-21]. (In Chinese).
[44] National Medical Products Administration. Notice on printing and distribution of the implementation guidence on the establishment of the national essential drug list system. https://www.nmpa.gov.cn/directory/web/nmpa/zhuanti/lshzht/shhwshgg/20090818151301303.html. [2021-03-21]. (In Chinese).
[45] Pereira M, Lunet N, Azevedo A, et al. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens, 2009; 27, 963−75. doi:  10.1097/HJH.0b013e3283282f65
[46] Wu YF, Benjamin EJ, MacMahon S. Prevention and control of cardiovascular disease in the rapidly changing economy of China. Circulation, 2016; 133, 2545−60. doi:  10.1161/CIRCULATIONAHA.115.008728
[47] Li X, Lu JP, Hu S, et al. The primary health-care system in China. Lancet, 2017; 390, 2584−94. doi:  10.1016/S0140-6736(17)33109-4
[48] Donaldson EA, Waters HR, Arora M, et al. A cost-effectiveness analysis of India's 2008 prohibition of smoking in public places in Gujarat. Int J Environ Res Public Health, 2011; 8, 1271−86. doi:  10.3390/ijerph8051271
[49] Gaudreau K, Sanford CJ, Cheverie C, et al. The effect of a smoking ban on hospitalization rates for cardiovascular and respiratory conditions in Prince Edward Island, Canada. PLoS One, 2013; 8, e56102. doi:  10.1371/journal.pone.0056102
[50] China Development Research Foundation. Aging population: China's development trends and policy options. China Development Press. 2020. (In Chinese)
[51] Liang K, Wang C, Yan F, et al. Analysis of cardiovascular risk factors in newly defined stage 1 hypertension among Chinese on the basis of the 2017 ACC/AHA hypertension guidelines. Biomed Environ Sci, 2020; 33, 48−52.
[52] Yu D, Du ML, Sun DJ, et al. Characteristics of hypertension death in low-income regions of Inner Mongolia, China. Biomed Environ Sci, 2020; 33, 53−7.
[53] Wang SH, Chen YY, Huang JL, et al. Spatial relationships between alcohol outlet densities and drunk driving crashes: an empirical study of Tianjin in China. J Safety Res, 2020; 74, 17−25. doi:  10.1016/j.jsr.2020.04.011